Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy
Open Access
- 1 September 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (5), 1544-1551
- https://doi.org/10.1182/blood-2004-11-4365
Abstract
NKG2D is an activating cell-surface receptor expressed on natural killer (NK) cells and some T-cell subsets. Its ligands are primarily expressed on tKeywords
This publication has 50 references indexed in Scilit:
- Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell functionCancer Gene Therapy, 2004
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ CellsThe Journal of Experimental Medicine, 2002
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- A Fas-based suicide switch in human T cells for the treatment of graft-versus-host diseaseBlood, 2001
- The Role of Chemokine Receptors in Primary, Effector, and Memory Immune ResponsesAnnual Review of Immunology, 2000
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985